| 注册
首页|期刊导航|实用临床医药杂志|沙利度胺联合化疗治疗35例恶性肿瘤临床疗效观察

沙利度胺联合化疗治疗35例恶性肿瘤临床疗效观察

张芫

实用临床医药杂志2011,Vol.15Issue(9):69-70,2.
实用临床医药杂志2011,Vol.15Issue(9):69-70,2.

沙利度胺联合化疗治疗35例恶性肿瘤临床疗效观察

The observation of clinical effect on Thalidomide combined withchemotherapy in 35 cases with cancer

张芫1

作者信息

  • 1. 广西桂林南溪山医院,药剂科,广西,桂林,541002
  • 折叠

摘要

Abstract

Objective To observe the clinical efficacy and adverse reactions on Thalidomide combined with chemotherapy in the treatment of malignant tumors. Methods From June 2007 to December 2009, 35 patients with malignant tumors were treated by thalidomide combined chemotherapy treatment, and the short - term clinical efficacy and side effects were observed. Resuits Therapeutic efficacy of thirty - five patients was 54.3 %, and clinical benefit rate was 94.3 %. Varying degrees of gastrointestinal tract, blood system and skin reactions occurred. Among 35 patients, life quality improved in 19 patients (54.3%), normal sleeping occurred in 20 cases (57.1% ), and body weight improved in 17 cases (48.6 % ). Conclusion Thalidomide combined with chemotherapy for cancer is generally effective with light side effects and patients' compliance is good.

关键词

肿瘤,恶性/沙利度胺/化疗

Key words

malignant/ thalidomide/ chemotherapy

分类

医药卫生

引用本文复制引用

张芫..沙利度胺联合化疗治疗35例恶性肿瘤临床疗效观察[J].实用临床医药杂志,2011,15(9):69-70,2.

实用临床医药杂志

OACSTPCD

1672-2353

访问量0
|
下载量0
段落导航相关论文